Some details for Covidien's (COV) pharmaceuticals business spin-off (previous): Shareholders...


Some details for Covidien's (COV) pharmaceuticals business spin-off (previous): Shareholders will receive one share of the new publicly traded company (Mallinckrodt) for every eight shares of COV they own. Mallinckrodt is expected to begin trading on the NYSE on July 1 (ticker: MNK). (PR)

From other sites
Comments (3)
  • Spin63
    , contributor
    Comments (23) | Send Message
     
    Correction - it's one share of MNK for every 8 shares of COV
    24 May 2013, 09:39 AM Reply Like
  • JRF77
    , contributor
    Comments (120) | Send Message
     
    Right. Eight shares, not one share. Record date 6/19, payable 6/28. Can anyone find a WI market? And the Bloomberg symbol?
    24 May 2013, 11:41 AM Reply Like
  • Colin Lokey
    , contributor
    Comments (469) | Send Message
     
    Correction was made on this MC.
    24 May 2013, 03:29 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs